InsidersTradesSigma
바이오노트: directors' dealings · South Korea · DART (FSS)
DART:company-17bbc0KR·DART (FSS)Mcap 509.2Bn€Healthcare
Explore the full directors' dealings record of 바이오노트, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 바이오노트 has published 5 public disclosures. Market capitalisation: €509.2bn. The latest transaction was reported on 21 April 2026 — Purchase. Among the most active insiders: 바이오노트. Every trade is openly available.
5
Insider Decl.
0
Thresholds
€1m
3 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
5030.00 €
Analyst consensus
Income statement
Revenue118.32 Bn€
Gross profit65.77 Bn€56% margin
Net income−87.50 Bn€-73.9% margin
Valuation
Beta0.70
Balance sheet & cash
Market cap509.22 Bn€
Total debt3.65 Bn€
Free Cash Flow6.11 Bn€
Debt / Equity0%
Profitability & ownership
ROE-5.6%
ROA0.6%
% insiders80.3%
% institutions6.0%
Last declaration on 21 April 2026
Declarations5 total
Executives●Other0DART
DART:20260311004474·details not loaded
Executives●Other0DART
DART:20260310002890·details not loaded
5 of 5 declarations